Interrelationships among metabolic syndrome, bone-derived cytokines, and the most common metabolic syndrome-related diseases negatively affecting bone quality.
Article in Diabetology & Metabolic Syndrome (September 2024)
The most recent citing publications are shown below. View all 57 publications that cite this research output on Dimensions.
SGLT2 inhibitors: a novel therapy for cognitive impairment via multifaceted effects on the nervous system
Article in Translational Neurodegeneration (August 2024)
SGLT2 inhibitors and nephrolithiasis risk: a meta-analysis
Article in Nephrology Dialysis Transplantation (August 2024)